How safe is a standard-risk child with ALL?

Jeanette Falck Winther; K. Schmiegelow

doi:10.1016/s1470-2045(14)70294-3

How safe is a standard-risk child with ALL?

Jeanette Falck Winther, K. Schmiegelow

Department of Clinical Medicine

8 Citations (Scopus)

Original language	English
Journal	Lancet Oncology
Volume	15
Issue number	8
Pages (from-to)	782-783
Number of pages	2
ISSN	1470-2045
DOIs	https://doi.org/10.1016/s1470-2045(14)70294-3
Publication status	Published - Jul 2014

Keywords

Antineoplastic Combined Chemotherapy Protocols
Female
Humans
Male
Neoplasms, Second Primary
Population Surveillance
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Access to Document

10.1016/s1470-2045(14)70294-3

Cite this

@article{bcc8587420d44a8ba178241a2daebf63,

title = "How safe is a standard-risk child with ALL?",

keywords = "Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Male, Neoplasms, Second Primary, Population Surveillance, Precursor Cell Lymphoblastic Leukemia-Lymphoma",

author = "Winther, {Jeanette Falck} and K. Schmiegelow",

year = "2014",

month = jul,

doi = "10.1016/s1470-2045(14)70294-3",

language = "English",

volume = "15",

pages = "782--783",

journal = "The Lancet Oncology",

issn = "1470-2045",